Probability of member receiving $1,000 is 0.026%. If you don’t make a selection in 45 days, you’ll no longer qualify for the promo. Customer must fund their account with a minimum of $50.00 to qualify. Probability percentage is subject to decrease.
Terms and conditions apply*. For 401k rollovers, existing SoFi IRA members must complete 401k rollovers via this link See full terms and For SoFi members without a SoFi IRA, a SoFi IRA must first be opened, and 401k rollover must be completed utilizing Capitalize via this link. SoFi and Capitalize will charge no additional fees to process a 401(k) rollover to a SoFi IRA. SoFi is not liable for any costs incurred from the existing 401k provider for rollover. Please check with your 401k provider for any fees or costs associated with the rollover. For IRA contributions, only deposits made via ACH and cash transfer from SoFi Bank accounts are eligible for the match. Click here for the 1% Match terms and conditions.
Must be a SoFi Plus member at the time a recurring deposit is received into your SoFi Active or Automated investing account to qualify. Bonus calculated on net monthly recurring deposits made via ACH and paid out as Rewards Points. See Rewards Terms of Service. SoFi reserves the right to change or terminate this promotion at any time without notice. See terms and limitations. https://www.sofi.com/sofiplus/invest/#disclaimers
Probability of member receiving $1,000 is 0.026%. If you don’t make a selection in 45 days, you’ll no longer qualify for the promo. Customer must fund their account with a minimum of $50.00 to qualify. Probability percentage is subject to decrease.
Terms and conditions apply*. For 401k rollovers, existing SoFi IRA members must complete 401k rollovers via this link See full terms and For SoFi members without a SoFi IRA, a SoFi IRA must first be opened, and 401k rollover must be completed utilizing Capitalize via this link. SoFi and Capitalize will charge no additional fees to process a 401(k) rollover to a SoFi IRA. SoFi is not liable for any costs incurred from the existing 401k provider for rollover. Please check with your 401k provider for any fees or costs associated with the rollover. For IRA contributions, only deposits made via ACH and cash transfer from SoFi Bank accounts are eligible for the match. Click here for the 1% Match terms and conditions.
Must be a SoFi Plus member at the time a recurring deposit is received into your SoFi Active or Automated investing account to qualify. Bonus calculated on net monthly recurring deposits made via ACH and paid out as Rewards Points. See Rewards Terms of Service. SoFi reserves the right to change or terminate this promotion at any time without notice. See terms and limitations. https://www.sofi.com/sofiplus/invest/#disclaimers
eToro securities trading offered by eToro USA Securities, Inc. (‘the BD”), member of FINRA and SIPC. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. Finder is not an affiliate and may be compensated if you access certain products or services offered by the BD.
5566dec9-e72f-402f-93ca-81f60f70b938-1% match on IRA contributions
1% match on IRA contributions
$0 commission on stocks, ETFs and options, with no options contract fees
Earn a rebate on every contract traded
Get 3.8% APY on your cash
Bio-Rad Laboratories is a medical devices business based in the US. Bio-Rad Laboratories shares (BIO) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $282.44 – a decrease of 2.59% over the previous week. Bio-Rad Laboratories employs 7,450 staff and has a trailing 12-month revenue of around $2.6 billion.
Open an account.Provide your personal information and sign up.
Fund your account.Deposit funds into your account by linking your banking information or transfer funds from another trading account.
Search for the stock name – BIO.Search for the stock by name or ticker symbol.
Buy the stock. Place your order. It's that simple.
Buy Bio-Rad Laboratories stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.
8 of 8 results
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on eight different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Bio-Rad Laboratories stock price (NYSE: BIO)
Use our graph to track the performance of BIO stocks over time.
Is it a good time to buy Bio-Rad Laboratories stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Bio-Rad Laboratories price performance over time
Historical closes compared with the close of $282.44 from 2026-06-18
1 week (2026-06-16)
-2.59%
1 month (2026-05-22)
-1.84%
3 months (2026-03-23)
6.58%
6 months (2025-12-23)
-6.18%
1 year (2025-06-23)
19.91%
2 years (2024-06-21)
-1.92%
3 years (2023-06-23)
-22.79%
5 years (2021-06-23)
-54.87%
Is Bio-Rad Laboratories stock undervalued or overvalued?
Valuing Bio-Rad Laboratories stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Bio-Rad Laboratories's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Bio-Rad Laboratories's P/E ratio
Bio-Rad Laboratories's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 47x. In other words, Bio-Rad Laboratories shares trade at around 47x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Bio-Rad Laboratories's PEG ratio
Bio-Rad Laboratories's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.1905. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Bio-Rad Laboratories's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Bio-Rad Laboratories's EBITDA
Bio-Rad Laboratories's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $444.8 million.
The EBITDA is a measure of a Bio-Rad Laboratories's overall financial performance and is widely used to measure a its profitability.
Bio-Rad Laboratories financials
Revenue TTM
$2.6 billion
Operating margin TTM
5.76%
Gross profit TTM
$1.3 billion
Return on assets TTM
1.79%
Return on equity TTM
2.5%
Profit margin
6.52%
Book value
$255.37
Market Capitalization
$7.6 billion
EBITDA
$444.8 million
TTM: trailing 12 months
Bio-Rad Laboratories's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Bio-Rad Laboratories.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Bio-Rad Laboratories's total ESG risk score
Total ESG risk: 23.57
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Bio-Rad Laboratories's overall score of 23.57 (as at 12/31/2018) is pretty good – landing it in it in the 28th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Bio-Rad Laboratories is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Bio-Rad Laboratories's environmental score
Environmental score: 6.03/100
Bio-Rad Laboratories's environmental score of 6.03 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Bio-Rad Laboratories is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Bio-Rad Laboratories's social score
Social score: 16.8/100
Bio-Rad Laboratories's social score of 16.8 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Bio-Rad Laboratories is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Bio-Rad Laboratories's governance score
Governance score: 10.75/100
Bio-Rad Laboratories's governance score puts it squarely in the 6th percentile of companies rated in the same sector. That could suggest that Bio-Rad Laboratories is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Bio-Rad Laboratories's controversy score
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Bio-Rad Laboratories scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Bio-Rad Laboratories has, for the most part, managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
Bio-Rad Laboratories Inc was last rated for ESG on: 2019-01-01.
Total ESG score
23.57
Total ESG percentile
27.74
Environmental score
6.03
Environmental score percentile
6
Social score
16.8
Social score percentile
6
Governance score
10.75
Governance score percentile
6
Level of controversy
2
Bio-Rad Laboratories share dividends
We're not expecting Bio-Rad Laboratories to pay a dividend over the next 12 months.
Have Bio-Rad Laboratories's shares ever split?
Bio-Rad Laboratories's shares were
split on a 2:1 basis on 7 March 2002
. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Bio-Rad Laboratories shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Bio-Rad Laboratories shares which in turn could have impacted Bio-Rad Laboratories's share price.
Bio-Rad Laboratories share price volatility
Over the last 12 months, Bio-Rad Laboratories's shares have ranged in value from as little as $228.4 up to $343.12. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Bio-Rad Laboratories's is 1.08. This would suggest that Bio-Rad Laboratories's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Frequently asked questions
What percentage of Bio-Rad Laboratories is owned by insiders or institutions? Currently 16.342% of Bio-Rad Laboratories shares are held by insiders and 94.398% by institutions.How many people work for Bio-Rad Laboratories? Latest data suggests 7,450 work at Bio-Rad Laboratories.When does the fiscal year end for Bio-Rad Laboratories? Bio-Rad Laboratories's fiscal year ends in December.Where is Bio-Rad Laboratories based? Bio-Rad Laboratories's address is: 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547What is Bio-Rad Laboratories's ISIN number? Bio-Rad Laboratories's international securities identification number is: US0905722072What is Bio-Rad Laboratories's CUSIP number? Bio-Rad Laboratories's Committee on Uniform Securities Identification Procedures number is: 090572207
How day trading works, what to watch out for and how to pick a broker.
Advertiser disclosure
Finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which Finder receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. Finder compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
How likely would you be to recommend Finder to a friend or colleague?
0
1
2
3
4
5
6
7
8
9
10
Very UnlikelyExtremely Likely
Required
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.
